from last pr: Xechem Nigeria's new commercial scale facility will have capacity to meet the demand of Nigeria and other African countries. Nigeria alone has 4 million sickle cell disease patients. The new facility will also be able to supply the drug for the clinical trials in the United States and the European Union.
Penny Stocks are not known to get multi million dollar loans, most are scams, XKEM is the REAL DEAL and this loan will be put to the plant to get full production up and running for greater production, more production more revenue, higher stock price.
News 
Market Data 
Discover 
